7h
Capt. Sully Reveals That His First Symptoms of Alzheimer's Were 'So Little, It Was Easy to Dismiss'
Capt. Chesley “Sully” Sullenberger III is speaking out about his early-stage Alzheimer’s diagnosis to help other families ...
Learn how brain tissue donated to science after death gives clues about genetic changes in neurological disorders and how we ...
Researchers believe hearing loss may make the brain work harder. At the cost of thinking and memory, it can also lead people ...
Census data shows 7 in 10 Miami-Dade seniors are Hispanic, a community already hit harder by Alzheimer's than others.
Citi’s Yigal Nochomovitz trimmed his price target to $33 from $40 and kept a Buy rating following the company’s update.
Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in precision proteomics dedicated to enabling the earliest detection of ...
New research indicates that changes in the brain's outer layer can be detected at least seven years before amyloid plaques ...
Alzheimer’s R&D is shifting toward disease modification, with amyloid, tau, RNA and immune targets driving trials, partnerships and oral therapy opportunities.Dublin, Sept. (GLOBE NEWSWIRE) -- ...
Sept 24 (Reuters) - Acadia Pharmaceuticals said on Thursday its experimental drug for psychosis associated with Alzheimer's missed the main goal of a mid-stage study testing whether it could reduce ...
Researchers hope the findings of new research could be used to develop treatments in the future.
The latest approvals expand the population of people who could be tested for the memory disorder—but experts warn the tests aren't for everyone.
Acadia Pharmaceuticals’ phase 2 Alzheimer’s disease trial has missed its primary endpoint, but the company and analysts alike ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results